Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

UPDATED: Hikma snaps up Boehringer sterile injectable assets for up to $300M

29.05.2014 / Fierce Pharma

Jordan's Hikma Pharmaceuticals has sewn up its deal to buy Bedford Laboratories, a struggling Ohio-based maker of injectable drugs owned by the Boehringer Ingelheim unit Ben Venue Laboratories.

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: